-
Adults (18-64 years)
-
Fragile population
-
People at high risk of STIs
-
Immunocompromised host
-
Men who have sex with men
-
People living with HIV
-
Hospital
-
Monkeypox virus
-
Adults (18-64 years)
-
General population
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Non pharmacological intervention
-
Rehabilitation
-
Neurostimulation
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Adolescents (12-17 years)
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Adults (18-64 years)
-
General population
-
Monkeypox virus
-
Pharmacological intervention
-
Vaccination
-
VAC∆6
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Non pharmacological intervention
-
Hydroxy gas
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Pharmacological intervention
-
Monoclonal antibodies
-
Temelimab
-
Adults (18-64 years)
-
General population
-
Hospital
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Adults (18-64 years)
-
General population
-
Outpatient clinic
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Adults (18-64 years)
-
Fragile population
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Non pharmacological intervention
-
Rehabilitation